Mesenchymal stem cell therapy for acute radiation syndrome: Innovative medical approaches in military medicine

Erik B. Eaton Jr.; Timothy R. Varney

doi:10.1186/s40779-014-0027-9

Your Location：

Home >

Browse articles >

Mesenchymal stem cell therapy for acute radiation syndrome: Innovative medical approaches in military medicine

REVIEW | Updated：2026-03-12

- Mesenchymal stem cell therapy for acute radiation syndrome: Innovative medical approaches in military medicine
- Mesenchymal stem cell therapy for acute radiation syndrome: Innovative medical approaches in military medicine
- MMR 2014年1卷第3期页码：186-195
- Affiliations：
  
  United States Army Medical Research Institute of Chemical Defense, 3100 Ricketts Point Road, Aberdeen Proving Ground, Maryland 21010, US
- Author bio：
  
  *: timothy.r.varney2.civ@mail.mil
- Funds：
- DOI：10.1186/s40779-014-0027-9
  中图分类号：
- 纸质出版：2014-09
- Accepted：
Scan QR Code
Mesenchymal stem cell therapy for acute radiation syndrome: Innovative medical approaches in military medicine[J]. MMR, 2014,1(3):186-195.

Eaton et al.: Rationale for the evaluation of mesenchymal stem cell therapy for the treatment of acute radiation syndrome. Mil Med Res 2014, 1: 27
Mesenchymal stem cell therapy for acute radiation syndrome: Innovative medical approaches in military medicine[J]. MMR, 2014,1(3):186-195. DOI： 10.1186/s40779-014-0027-9.

Eaton et al.: Rationale for the evaluation of mesenchymal stem cell therapy for the treatment of acute radiation syndrome. Mil Med Res 2014, 1: 27 DOI： 10.1186/s40779-014-0027-9.

摘要

Abstract

After a radiological or nuclear event

acute radiation syndrome (ARS) will present complex medical challenges that could involve the treatment of hundreds to thousands of patients. Current medical doctrine is based on limited clinical data and remains inadequate. Efforts to develop medical innovations that address ARS complications are unlikely to be generated by the industry because of market uncertainties specific to this type of injury. A prospective strategy could be the integration of cellular therapy to meet the medical demands of ARS. The most clinically advanced cellular therapy to date is the administration of mesenchymal stem cells (MSCs). Results of currently published investigations describing MSC safety and efficacy in a variety of injury and disease models demonstrate the unique qualities of this reparative cell population in adapting to the specific requirements of the damaged tissue in which the cells integrate. This report puts forward a rationale for the further evaluation of MSC therapy to address the current unmet medical needs of ARS. We propose that the exploration of this novel therapy for the treatment of the multivariate complications of ARS could be of invaluable benefit to military medicine.

关键词

Keywords

references

Waselenko JK , MacVittie TJ , Blakely WF , Pesik N , Wiley AL , Dickerson WE , Tsu H , Confer DL , Coleman CN , Seed T , Lowry P , Armitage JO , Dainiak N; Strategic National Stockpile Radiation Working Group : Medical management of the acute radiation syndrome: recommendations of the Strategic National Stockpile Radiation Working Group . Ann Intern Med 2004 , 140 : 1037 - 1051 .

Gurudutta GU , Satija NK , Singh VK , Verma YK , Gupta P , Tripathi RP : Stem cell therapy: a novel & futuristic treatment modality for disaster injuries . Indian J Med Res 2012 , 135 : 15 - 25 .

ClinicalTrials.gov [ http://clinicaltrials.gov/ http://clinicaltrials.gov/ ]

Pittenger MF , Martin BJ : Mesenchymal stem cells and their potential as cardiac therapeutics . Circ Res 2004 , 95 : 9 - 20 .

Chen J , Chopp M : Neurorestorative treatment of stroke: cell and pharmacological approaches . NeuroRx 2006 , 3 : 466 - 473 .

Pittenger MF , Mackay AM , Beck SC , Jaiswal RK , Douglas R , Mosca JD , Moorman MA , Simonetti DW , Craig S , Marshak DR : Multilineage potential of adult human mesenchymal stem cells . Science 1999 , 284 : 143 - 147 .

Meirelles Lda S , Fontes AM , Covas DT , Caplan AI : Mechanisms involved in the therapeutic properties of mesenchymal stem cells . Cytokine Growth Factor Rev 2009 , 20 : 419 - 427 .

Wang L , Li Y , Chen X , Chen J , Gautam SC , Xu Y , Chopp M : MCP-1, MIP-1, IL-8 and ischemic cerebral tissue enhance human bone marrow stromal cell migration in interface culture . Hematology 2002 , 7 : 113 - 117 .

Askari AT , Unzek S , Popovic ZB , Goldman CK , Forudi F , Kiedrowski M , Rovner A , Ellis SG , Thomas JD , DiCorleto PE , Topol EJ , Penn MS : Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy . Lancet 2003 , 362 : 697 - 703 .

Calkoen FG , Brinkman DM , Vervat C , van Ostaijen-Ten Dam MM , Ten Cate R , van Tol MJ , Ball LM : Mesenchymal stromal cells isolated from children with systemic juvenile idiopathic arthritis suppress innate and adaptive immune responses . Cytotherapy 2013 , 15 : 280 - 291 .

Neuss S , Becher E , Woltje M , Tietze L , Jahnen-Dechent W : Functional expression of HGF and HGF receptor/c-met in adult human mesenchymal stem cells suggests a role in cell mobilization, tissue repair, and wound healing . Stem Cells 2004 , 22 : 405 - 414 .

Chen J , Li Y , Katakowski M , Chen X , Wang L , Lu D , Lu M , Gautam SC , Chopp M : Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat . J Neurosci Res 2003 , 73 : 778 - 786 .

Inamdar AC , Inamdar AA : Mesenchymal stem cell therapy in lung disorders: pathogenesis of lung diseases and mechanism of action of mesenchymal stem cell . Experimental lung research 2013 , 39 : 315 - 327 .

Sheng CC , Zhou L , Hao J : Current stem cell delivery methods for myocardial repair . BioMed research international 2013 , 2013 : 547902 .

Honmou O , Onodera R , Sasaki M , Waxman SG , Kocsis JD : Mesenchymal stem cells: therapeutic outlook for stroke . Trends in molecular medicine 2012 , 18 : 292 - 297 .

De Miguel MP , Fuentes-Julian S , Blazquez-Martinez A , Pascual CY , Aller MA , Arias J , Arnalich-Montiel F : Immunosuppressive properties of mesenchymal stem cells: advances and applications . Current molecular medicine 2012 , 12 : 574 - 591 .

Donnelly EH , Nemhauser JB , Smith JM , Kazzi ZN , Farfan EB , Chang AS , Naeem SF : Acute radiation syndrome: assessment and management . South Med J 2010 , 103 : 541 - 546 .

Majumdar MK , Thiede MA , Mosca JD , Moorman M , Gerson SL : Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells . J Cell Physiol 1998 , 176 : 57 - 66 .

Mourcin F , Grenier N , Mayol JF , Lataillade JJ , Sotto JJ , Herodin F , Drouet M : Mesenchymal stem cells support expansion of in vitro irradiated CD34(+) cells in the presence of SCF, FLT3 ligand, TPO and IL3: potential application to autologous cell therapy in accidentally irradiated victims . Radiat Res 2005 , 164 : 1 - 9 .

Wang JF , Wu YF , Harrintong J , McNiece IK : Ex vivo expansions and transplantations of mouse bone marrow-derived hematopoietic stem/progenitor cells . J Zhejiang Univ Sci 2004 , 5 : 157 - 163 .

Angelopoulou M , Novelli E , Grove JE , Rinder HM , Civin C , Cheng L , Krause DS : Cotransplantation of human mesenchymal stem cells enhances human myelopoiesis and megakaryocytopoiesis in NOD/SCID mice . Exp Hematol 2003 , 31 : 413 - 420 .

Maitra B , Szekely E , Gjini K , Laughlin MJ , Dennis J , Haynesworth SE , Koc ON : Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation . Bone Marrow Transplant 2004 , 33 : 597 - 604 .

Kim DW , Chung YJ , Kim TG , Kim YL , Oh IH : Cotransplantation of third-party mesenchymal stromal cells can alleviate single-donor predominance and increase engraftment from double cord transplantation . Blood 2004 , 103 : 1941 - 1948 .

Tolar J , Le Blanc K , Keating A , Blazar BR : Concise review: hitting the right spot with mesenchymal stromal cells . Stem Cells 2010 , 28 : 1446 - 1455 .

Ball LM , Bernardo ME , Roelofs H , Lankester A , Cometa A , Egeler RM , Locatelli F , Fibbe WE : Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation . Blood 2007 , 110 : 2764 - 2767 .

Koc ON , Gerson SL , Cooper BW , Dyhouse SM , Haynesworth SE , Caplan AI , Lazarus HM : Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy . J Clin Oncol 2000 , 18 : 307 - 316 .

Amadori S , Suciu S , Jehn U , Stasi R , Thomas X , Marie JP , Muus P , Lefrère F , Berneman Z , Fillet G , Denzlinger C , Willemze R , Leoni P , Leone G , Casini M , Ricciuti F , Vignetti M , Beeldens F , Mandelli F , De Witte T; EORTC/GIMEMA Leukemia Group : Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study . Blood 2005 , 106 : 27 - 34 .

Usuki K , Urabe A , Masaoka T , Ohno R , Mizoguchi H , Hamajima N , Miyazaki T , Niitsu Y , Yoshida Y , Miura A , Shibata A , Abe T , Miura Y , Ikeda Y , Nomura T , Nagao T , Saitou H , Shirakawa S , Ohkuma M , Matsuda T , Nakamura T , Horiuchi A , Kuramoto A , Kimura I , Irino S , Niho Y , Takatsuki K , Tomonaga M , Uchino H , Takaku F; Gran AML Study Group : Efficacy of granulocyte colony-stimulating factor in the treatment of acute myelogenous leukaemia: a multicentre randomized study . Br J Haematol 2002 , 116 : 103 - 112 .

Nivison-Smith I , Bradstock KF , Szer J , Durrant S , Dodds A , Hermann R , Schwarer AP , Gibson J , To LB , Arthur C , Australian Bone Marrow Transplant Cooperative Sutdy G : Allogeneic haemopoietic cell transplants in Australia, 1996--a multi-centre retrospective comparison of the use of peripheral blood stem cells with bone marrow . Bone Marrow Transplant 2001 , 28 : 21 - 27 .

Godwin JE , Kopecky KJ , Head DR , Willman CL , Leith CP , Hynes HE , Balcerzak SP , Appelbaum FR : A double-blind placebo-controlled trial of granulocyte colony-stimulating factor in elderly patients with previously untreated acute myeloid leukemia: a Southwest oncology group study (9031) . Blood 1998 , 91 : 3607 - 3615 .

Löwenberg B , Boogaerts MA , Daenen SM , Verhoef GE , Hagenbeek A , Vellenga E , Ossenkoppele GJ , Huijgens PC , Verdonck LF , van der Lelie J , Wielenga JJ , Schouten HC , Gmür J , Gratwohl A , Hess U , Fey MF , van Putten WL : Value of different modalities of granulocyte-macrophage colony-stimulating factor applied during or after induction therapy of acute myeloid leukemia . J Clin Oncol 1997 , 15 : 3496 - 3506 .

Hassan HT , Zander AR : Thrombocytopenia after high-dose chemotherapy and autologous stem cell transplantation: an unresolved problem and possible approaches to resolve it . Journal of hematotherapy 1996 , 5 : 407 - 414 .

Rowe JM , Andersen JW , Mazza JJ , Bennett JM , Paietta E , Hayes FA , Oette D , Cassileth PA , Stadtmauer EA , Wiernik PH : A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490) . Blood 1995 , 86 : 457 - 462 .

Stone RM , Berg DT , George SL , Dodge RK , Paciucci PA , Schulman P , Lee EJ , Moore JO , Powell BL , Schiffer CA : Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. Cancer and Leukemia Group B . The New England journal of medicine 1995 , 332 : 1671 - 1677 .

Ottmann OG , Hoelzer D , Gracien E , Ganser A , Kelly K , Reutzel R , Lipp T , Busch FW , Schwonzen M , Heil G , Wandt H , Koch P , Kolbe K , Heyll A , Bentz M , Peters S , Helmut Diedrich H , Jurgen Dethling J , Peter Meyer P , Mohamed R. Nowrousian M , Leffler B , Weiss A , Kneba M , Faller A , Graf M , Hecht T : Concomitant granulocyte colony-stimulating factor and induction chemoradiotherapy in adult acute lymphoblastic leukemia: a randomized phase III trial . Blood 1995 , 86 : 444 - 450 .

Hu KX , Sun QY , Guo M , Ai HS : The radiation protection and therapy effects of mesenchymal stem cells in mice with acute radiation injury . Br J Radiol 2010 , 83 : 52 - 58 .

Lange C , Brunswig-Spickenheier B , Cappallo-Obermann H , Eggert K , Gehling UM , Rudolph C , Schlegelberger B , Cornils K , Zustin J , Spiess AN , Zander AR : Radiation rescue: mesenchymal stromal cells protect from lethal irradiation . PLoS One 2011 , 6 : e14486 .

Fouillard L , Bensidhoum M , Bories D , Bonte H , Lopez M , Moseley AM , Smith A , Lesage S , Beaujean F , Thierry D , Gourmelon P , Najman A , Gorin NC : Engraftment of allogeneic mesenchymal stem cells in the bone marrow of a patient with severe idiopathic aplastic anemia improves stroma . Leukemia 2003 , 17 : 474 - 476 .

Fouillard L , Chapel A , Bories D , Bouchet S , Costa JM , Rouard H , Herve P , Gourmelon P , Thierry D , Lopez M , Gorin NC : Infusion of allogeneic-related HLA mismatched mesenchymal stem cells for the treatment of incomplete engraftment following autologous haematopoietic stem cell transplantation . Leukemia 2007 , 21 : 568 - 570 .

Meuleman N , Tondreau T , Ahmad I , Kwan J , Crokaert F , Delforge A , Dorval C , Martiat P , Lewalle P , Lagneaux L , Bron D : Infusion of mesenchymal stromal cells can aid hematopoietic recovery following allogeneic hematopoietic stem cell myeloablative transplant: a pilot study . Stem Cells Dev 2009 , 18 : 1247 - 1252 .

Saha S , Bhanja P , Kabarriti R , Liu L , Alfieri AA , Guha C : Bone marrow stromal cell transplantation mitigates radiation-induced gastrointestinal syndrome in mice . PLoS One 2011 , 6 : e24072 .

Kinnaird T , Stabile E , Burnett MS , Lee CW , Barr S , Fuchs S , Epstein SE : Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms . Circ Res 2004 , 94 : 678 - 685 .

Semont A , Francois S , Mouiseddine M , Francois A , Sache A , Frick J , Thierry D , Chapel A : Mesenchymal stem cells increase self-renewal of small intestinal epithelium and accelerate structural recovery after radiation injury . Adv Exp Med Biol 2006 , 585 : 19 - 30 .

Voswinkel J , Francois S , Simon JM , Benderitter M , Gorin NC , Mohty M , Fouillard L , Chapel A : Use of Mesenchymal Stem Cells (MSC) in Chronic Inflammatory Fistulizing and Fibrotic Diseases: a Comprehensive Review . Clin Rev Allergy Immunol 2013 .

Ringdén O , Uzunel M , Rasmusson I , Remberger M , Sundberg B , Lönnies H , Marschall HU , Dlugosz A , Szakos A , Hassan Z , Omazic B , Aschan J , Barkholt L , Le Blanc K : Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease . Transplantation 2006 , 81 : 1390 - 1397 .

Duijvestein M , Vos AC , Roelofs H , Wildenberg ME , Wendrich BB , Verspaget HW , Kooy-Winkelaar EM , Koning F , Zwaginga JJ , Fidder HH , Verhaar AP , Fibbe WE , van den Brink GR , Hommes DW : Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn’s disease: results of a phase I study . Gut 2010 , 59 : 1662 - 1669 .

MacVittie TJ , Farese AM , Bennett A , Gelfond D , Shea-Donohue T , Tudor G , Booth C , McFarland E , Jackson W, 3rd : The acute gastrointestinal subsyndrome of the acute radiation syndrome: a rhesus macaque model . Health Phys 2012 , 103 : 411 - 426 .

Kim JW , Lee JH , Lyoo YS , Jung DI , Park HM : The effects of topical mesenchymal stem cell transplantation in canine experimental cutaneous wounds . Vet Dermatol 2013 , 24 : 242 - e253 .

Shumakov VI , Onishchenko NA , Rasulov MF , Krasheninnikov ME , Zaidenov VA : Mesenchymal bone marrow stem cells more effectively stimulate regeneration of deep burn wounds than embryonic fibroblasts . Bull Exp Biol Med 2003 , 136 : 192 - 195 .

Francois S , Mouiseddine M , Mathieu N , Semont A , Monti P , Dudoignon N , Sache A , Boutarfa A , Thierry D , Gourmelon P , Chapel A : Human mesenchymal stem cells favour healing of the cutaneous radiation syndrome in a xenogenic transplant model . Ann Hematol 2007 , 86 : 1 - 8 .

Lataillade JJ , Doucet C , Bey E , Carsin H , Huet C , Clairand I , Bottollier-Depois JF , Chapel A , Ernou I , Gourven M , Boutin L , Hayden A , Carcamo C , Buglova E , Joussemet M , de Revel T , Gourmelon P : New approach to radiation burn treatment by dosimetry-guided surgery combined with autologous mesenchymal stem cell therapy . Regen Med 2007 , 2 : 785 - 794 .

Bey E , Prat M , Duhamel P , Benderitter M , Brachet M , Trompier F , Battaglini P , Ernou I , Boutin L , Gourven M , Tissedre F , Créa S , Mansour CA , de Revel T , Carsin H , Gourmelon P , Lataillade JJ : Emerging therapy for improving wound repair of severe radiation burns using local bone marrow-derived stem cell administrations . Wound Repair Regen 2010 , 18 : 50 - 58 .

Hao L , Wang J , Zou Z , Yan G , Dong S , Deng J , Ran X , Feng Y , Luo C , Wang Y , Cheng T : Transplantation of BMSCs expressing hPDGF-A/hBD2 promotes wound healing in rats with combined radiation-wound injury . Gene Ther 2009 , 16 : 34 - 42 .

Mansilla E , Marín GH , Drago H , Sturla F , Salas E , Gardiner C , Bossi S , Lamonega R , Guzmán A , Nuñez A , Gil MA , Piccinelli G , Ibar R , Soratti C : Bloodstream cells phenotypically identical to human mesenchymal bone marrow stem cells circulate in large amounts under the influence of acute large skin damage: new evidence for their use in regenerative medicine . Transplant Proc 2006 , 38 : 967 - 969 .

Natsu K , Ochi M , Mochizuki Y , Hachisuka H , Yanada S , Yasunaga Y : Allogeneic bone marrow-derived mesenchymal stromal cells promote the regeneration of injured skeletal muscle without differentiation into myofibers . Tissue Eng 2004 , 10 : 1093 - 1112 .

Bruder SP , Kurth AA , Shea M , Hayes WC , Jaiswal N , Kadiyala S : Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells . J Orthop Res 1998 , 16 : 155 - 162 .

Liu H , Fan H , Toh SL , Goh JC : A comparison of rabbit mesenchymal stem cells and anterior cruciate ligament fibroblasts responses on combined silk scaffolds . Biomaterials 2008 , 29 : 1443 - 1453 .

Ortiz LA , Gambelli F , McBride C , Gaupp D , Baddoo M , Kaminski N , Phinney DG : Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects . Proc Natl Acad Sci U S A 2003 , 100 : 8407 - 8411 .

Chao YX , He BP , Tay SS : Mesenchymal stem cell transplantation attenuates blood brain barrier damage and neuroinflammation and protects dopaminergic neurons against MPTP toxicity in the substantia nigra in a model of Parkinson’s disease . J Neuroimmunol 2009 , 216 : 39 - 50 .

Schulman IH , Hare JM : Key developments in stem cell therapy in cardiology . Regen Med 2012 , 7 : 17 - 24 .

Ma Y , Xu Y , Xiao Z , Yang W , Zhang C , Song E , Du Y , Li L : Reconstruction of chemically burned rat corneal surface by bone marrow-derived human mesenchymal stem cells . Stem Cells 2006 , 24 : 315 - 321 .

Oh JY , Kim MK , Shin MS , Lee HJ , Ko JH , Wee WR , Lee JH : The anti-inflammatory and anti-angiogenic role of mesenchymal stem cells in corneal wound healing following chemical injury . Stem Cells 2008 , 26 : 1047 - 1055 .

Parekkadan B , van Poll D , Suganuma K , Carter EA , Berthiaume F , Tilles AW , Yarmush ML : Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure . PLoS One 2007 , 2 : e941 .

Togel F , Hu Z , Weiss K , Isaac J , Lange C , Westenfelder C : Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms . Am J Physiol Renal Physiol 2005 , 289 : F31 - 42 .

Varney TR , Bowens CM , Eaton EB , Lehman JG : Production Methods for a Mesenchymal Stem Cell Therapeutic as a Medical Defense Countermeasure. 2012, USAMRICD-TR-12-02 . US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground . ADA558893 .

Basciano L , Nemos C , Foliguet B , de Isla N , de Carvalho M , Tran N , Dalloul A : Long term culture of mesenchymal stem cells in hypoxia promotes a genetic program maintaining their undifferentiated and multipotent status . BMC Cell Biol 2011 , 12 : 12 .

Le Blanc K , Rasmusson I , Sundberg B , Gotherstrom C , Hassan M , Uzunel M , Ringden O : Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells . Lancet 2004 , 363 : 1439 - 1441 .

浏览量

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Mesenchymal stem cell therapy for acute radiation syndrome

Apoptosis-resistant megakaryocytes produce large and hyperreactive platelets in response to radiation injury

Mesenchymal stem cell-derived extracellular vesicles in skin wound healing: the risk of senescent drift induction in secretome-based therapeutics